Histamine Toxicity Market 2024 – Market Size & Segments Analysis, Industry Trends, Manufacturers Analysis, Opportunities and Forecast 2030

Page: 215 | Report Code: LS24051502 | Research Suite: Report (PDF) & Market Data (Excel)

NOTE: Due to exhaustive nature of content, full ToC can't be uploaded. Please request Sample Pages to receive full table of content. 

The global market value of the histamine toxicity market was valued at USD 550.6 million in 2022, and a CAGR of 4.5% is expected during the forecast period. Histamine toxicity is a kind of food poisoning that is related to eating spoiled fish. It includes diagnostic tests, medications like antihistamines, and preventive measures like proper food handling practices. It is driven by factors like food safety regulations, which increase consumer awareness about food safety. Increasing health consciousness among consumers is driving growth in the market significantly.

Rising healthcare expenditure by the government is also a reason behind the significant growth in this market. Histamine is caused by eating dark meat, such as tuna. Poor refrigeration or rotten seafood is also a major reason behind the histamine development. Lack of safety regulation is driving the growth of the market significantly. The increase in consumption of seafood, like canned fish, is driving the growth of the market.


Growth Drivers

Increasing awareness about hygienic food is driving the growth of the market significantly. The increasing incidence of foodborne diseases in the world is driving growth in the market. Governments worldwide are ensuring stricter regulations to ensure food safety, which drives the adoption of histamine detection methods and preventive measures in food processing and handling. Increased awareness of food safety and the potential health risks associated with histamine contamination is driving significant growth in the market.

Technological advancements in diagnostic tools and techniques are improving the efficiency and accuracy of histamine toxicity detection, fueling market growth. The expansion of the global food industry, including seafood processing, where histamine is common, is creating a larger market for histamine. Increasing healthcare expenditure, particularly in emerging economies, is enabling healthcare facilities to invest in advanced diagnostics and treatment options for histamine toxicity, which is driving market growth.

Ongoing research and development efforts to develop novel therapies for histamine toxicity are expected to further stimulate market growth by offering more effective treatment options. The increasing number of cases of histamine toxicity is driving growth in the market significantly. The market is driven by a lack of internationally harmonized safety standards and awareness about the diseases associated with them. Lack of awareness among people about the expiration dates of products is driving growth in the market significantly. The increasing prevalence of food allergies due to a lack of awareness of food hygiene is driving growth in the market. Lack of safety regulations on the fish trade is driving the demand in the histamine toxicity market.

Histamine Toxicity Segmentation

Drug Type

·         Anti-Histamine

·         Others

Route of Administration

·         Tropical

·         Oral

·         Nasal

Regional Outlook

·         Asia Pacific

·         North America

·         Latin America

·         Europe

·         Middle East and Africa

Histamine Toxicity Market Drug Type Segmentation

On the basis of drug type, the histamine toxicity market is segmented into anti-histamine and others. Antihistamine is a leading segment due to the fact that it is specifically designed to counteract the effects of histamine, the chemical responsible for allergic reactions and histamine toxicity. Anti-histamine works by blocking the action of histamine receptors.

It reduces symptoms such as itching, swelling, and inflammation. They are commonly used for both preventive measures and symptomatic relief, making them a key component in the histamine toxicity market. Increasing use of medicines in the form of tablets, capsules, and syrup is driving growth in the market significantly.


Histamine Toxicity Market by Route of Administration Segment

On the basis of the route of administration, the histamine toxicity market is segmented into tropical, oral, and nasal. The oral segment is the leading one in the histamine toxicity market due to the fact that the fact that oral administration of medicine is the most common and convenient route of delivery for treating histamine-related issues. Many antihistamines are used to manage toxicity and are available in oral form, like tablets, capsules, and syrup, making them easier to administer.

Oral medications have quick absorption and distribution throughout the body, allowing for rapid recovery. Due to increasing awareness about health hygiene and food-borne diseases, the market is significantly growing. Nasal is another leading segment due to the convenience of nasal delivery methods and increased awareness about histamine-related allergies. Nasal formulations offer faster onset of action and targeted delivery.

This method is appealing for both patients and healthcare providers. The increasing number of cases of histamine toxicity is driving growth in the market significantly. The increasing number of cases due to the use of canned fish is driving demand in the market significantly.

Regional Outlook

On the basis of the regions, the histamine toxicity market is segmented into 5 parts: Asia Pacific, North America, Latin America, Europe, and the Middle East and Africa. North America, particularly the United States, and Canada have stringent food safety regulations enforced by agencies like the FDA and CFIA. There is a high incidence of food-borne diseases, including histamine toxicity, due to factors such as increased consumption of seafood. The presence of major key players in the United States of America is the key reason behind the significant growth in the market.

The high cost of diagnostic tests is the reason behind the growth in the market. The Asia-Pacific market is a big player in the histamine toxicity market due to the large population consuming seafood, increasing awareness and illness, and improving healthcare infrastructure. Japan, China, India, and Australia are among the big players in the market, contributing to the market’s growth in this region. In Europe, the histamine toxicity market is influenced by stringent food safety regulations, growing concerns over foodborne illness, and advancements in diagnostic technologies.


Countries like Germany, France, Italy, and the UK are key players in this market, with a focus on the prevention, detection, and treatment of histamine-related issues. Latin America, including countries like Brazil, Argentina, Mexico, and Chile, is witnessing moderate growth in the market during the forecast period. South Africa and Egypt are also witnessing moderate growth due to a lack of awareness among the people. The increasing number of cases of foodborne allergies is driving growth in the market.

Key Players

·         Johnson and Johnson Company

·         Actavis Inc

·         Cipla Limited

·         Hindustan Liver Limited

·         Pfizer Inc

·         Teva Parenteral Limited

·         Sanofi Aventis Ltd

·         Sun Pharmaceuticals Ltd

·         Mylan Laboratories Ltd

·         McNell Consumer and Specialty pharmaceutical

·         Alembic Pharmaceuticals

·         Other Players

Buy Report